# BCPC — Balchem Corporation · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** BCPC  
**Sources:** 20  
**Published:** 2026-09-25  
**Canonical:** https://app.k3vl4r.com/research/deep-research-bcpc-balchem-corporation-catalysts-narrative-risks-3447

---

## Overview

Balchem Corporation (NASDAQ: BCPC) is a specialty ingredient manufacturer for health and nutrition markets, organized into three segments — Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [[1]](https://markets.businessinsider.com/news/stocks/balchem-corporation-to-participate-in-baird-s-global-industrial-conference-on-november-11-2026-1036676259), [[9]](https://balchem.com/news/balchem-reports-third-quarter-2026-financial-results/). As of mid-November 2026, the stock trades near $172–174 with a market capitalization of roughly $5.5 billion [[14]](https://tickernerd.com/stock/bcpc-forecast/), [[16]](https://www.stocktitan.net/overview/BCPC/), [[17]](https://stockanalysis.com/stocks/bcpc/).

## Recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-bcpc-balchem-corporation-catalysts-narrative-risks-3447 (free to sign up)._
